Clinical impact of beta-blocker withdrawal in transthyretin amyloid cardiomyopathy

Amyloid. 2024 Nov 20:1-3. doi: 10.1080/13506129.2024.2431082. Online ahead of print.

Authors

Eva Cabrera-Romero^{1

2}, Leidy Alexandra Serrao-Faria¹, Nerea Mora-Ayestarán^{1

2}, Belén Peiró-Aventín^{1

2}, Ana Espinoza¹, Daniel de Castro^{1

2}, Marta Cobo-Marcos¹, Fernando Domínguez^{1

2}, Esther González-López^{1

2}, Pablo Garcia-Pavia^{1

2}

Affiliations

¹ Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA, CIBERCV, Madrid, Spain.
² Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

PMID: 39565050
DOI: 10.1080/13506129.2024.2431082

No abstract available